Toggle navigation
Home
Search
Services
Blog
Contact
About
DMID Clinical Trial Management
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
Regulatory Mechanisms of Implant-Induced Osteolysis
Genetic Risk Factors for CVA in Children with Hb SS
Univ of Rochester Summer Res Prog for Disadv Hs Students
Recently added grants:
Heterogeneous Loss of GDF11 Tumor Suppression in Triple-negative Breast Cancer
FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
Specificity and function of memory-phenotype CD8+ T cells in the tumor environment
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI30068-13-0-1
Application #
7579675
Study Section
Project Start
2003-09-30
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
DMID Clinical Trial Management
/ Pharmaceutical Product Development
$3,388,782
NIH 2007
N01 AI
Dmid Clinical Trials Management
Batzold, Fred /
$33,425,003
NIH 2007
N01 AI
DMID Clinical Trial Management
/
NIH 2007
N01 AI
DMID Clinical Trial Management
/
Comments
Be the first to comment on this grant